In the last 12 months, insiders at Edwards Lifesciences Corp ($EW) filed 457 transactions with the SEC: 1 open-market purchases totaling $49,753 and 114 sales totaling $63,828,929. Net insider sentiment: net selling.
Edwards Lifesciences Corp operates in the Orthopedic, prosthetic & surgical appliances & supplies industry (Industrial Applications and Services sector).
Most Active Insiders
- BOBO DONALD E JR (CVP,Strategy/Corp Development) — 86 transactions totaling $26,215,156
- MUSSALLEM MICHAEL A (Director) — 24 transactions totaling $17,847,026
- Ullem Scott B. (CVP, Chief Financial Officer) — 67 transactions totaling $17,480,522
- Zovighian Bernard J (CEO) — 50 transactions totaling $11,827,380
- Szyman Catherine M. (CVP, Critical Care) — 17 transactions totaling $6,636,512
View all SEC Filings for Edwards Lifesciences Corp (EW).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 4676 | $80.59 | 199,960.8826 | 658,200,000 | 2.29% | 0.00% |
| April 2, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 18004 | $80.05 | 181,956.8826 | 658,200,000 | 9.00% | 0.00% |
| April 2, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 22680 | $0.00 | 0.0000 | 658,200,000 | 100.00% | 0.00% |
| April 2, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 22680 | $59.26 | 204,636.8826 | 658,200,000 | 12.46% | 0.00% |
| March 11, 2026 | Lippis Daniel J. | CVP, TAVR | S | Common Stock | 1019 | $85.38 | 33,933.9103 | 658,200,000 | 2.92% | 0.00% |
| March 11, 2026 | Lippis Daniel J. | CVP, TAVR | M | Common Stock | 1019 | $59.26 | 34,952.9103 | 658,200,000 | 3.00% | 0.00% |
| March 11, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 13000 | $59.26 | 319,017.0000 | 658,200,000 | 4.25% | 0.00% |
| March 11, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 5099 | $84.46 | 313,918.0000 | 658,200,000 | 1.60% | 0.00% |
| March 11, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 13000 | $0.00 | 26,000.0000 | 658,200,000 | 33.33% | 0.00% |
| March 11, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7901 | $85.21 | 306,017.0000 | 658,200,000 | 2.52% | 0.00% |
| March 11, 2026 | Lippis Daniel J. | CVP, TAVR | M | Employee Stock Option (Right to Acquire) | 1019 | $0.00 | 3,057.0000 | 658,200,000 | 25.00% | 0.00% |
| March 2, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 11340 | $59.26 | 193,262.8394 | 658,200,000 | 6.23% | 0.00% |
| March 2, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 11340 | $0.00 | 22,680.0000 | 658,200,000 | 33.33% | 0.00% |
| March 2, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 11340 | $85.93 | 181,922.8394 | 658,200,000 | 5.87% | 0.00% |
| Feb. 25, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 24000 | $83.84 | 181,922.8394 | 658,200,000 | 11.65% | 0.00% |
| Feb. 22, 2026 | Dahl Andrew M. | SVP, Corporate Controller | F | Common Stock | 176 | $79.78 | 9,089.4805 | 658,200,000 | 1.90% | 0.00% |
| Feb. 22, 2026 | Lippis Daniel J. | CVP, TAVR | F | Common Stock | 432 | $79.78 | 33,933.9103 | 658,200,000 | 1.26% | 0.00% |
| Feb. 16, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 199 | $75.87 | 306,017.0000 | 658,200,000 | 0.06% | 0.00% |
| Feb. 16, 2026 | Lippis Daniel J. | CVP, TAVR | F | Common Stock | 258 | $75.87 | 34,563.9103 | 658,200,000 | 0.74% | 0.00% |
| Feb. 17, 2026 | Lippis Daniel J. | CVP, TAVR | F | Common Stock | 198 | $75.87 | 34,365.9103 | 658,200,000 | 0.57% | 0.00% |
| Feb. 12, 2026 | Lippis Daniel J. | CVP, TAVR | A | Common Stock | 12820 | $0.00 | 34,821.9103 | 658,200,000 | 58.27% | 0.00% |
| Feb. 12, 2026 | Zovighian Bernard J | CEO | M | Common Stock | 25350 | $59.26 | 121,498.1365 | 658,200,000 | 26.37% | 0.00% |
| Feb. 12, 2026 | Zovighian Bernard J | CEO | S | Common Stock | 2532 | $77.13 | 118,966.1365 | 658,200,000 | 2.08% | 0.00% |
| Feb. 12, 2026 | Zovighian Bernard J | CEO | S | Common Stock | 19898 | $76.61 | 99,068.1365 | 658,200,000 | 16.73% | 0.00% |
| Feb. 13, 2026 | Zovighian Bernard J | CEO | G | Common Stock | 2920 | $0.00 | 96,148.1365 | 658,200,000 | 2.95% | 0.00% |
| Feb. 13, 2026 | Zovighian Bernard J | CEO | G | Common Stock | 2920 | $0.00 | 96,148.1365 | 658,200,000 | 3.13% | 0.00% |
| Feb. 12, 2026 | Zovighian Bernard J | CEO | M | Employee Stock Option (Right to Acquire) | 25350 | $0.00 | 0.0000 | 658,200,000 | 100.00% | 0.00% |
| Jan. 9, 2026 | Lippis Daniel J. | CVP, TAVR | S | Common Stock | 1019 | $85.70 | 22,001.9103 | 658,200,000 | 4.43% | 0.00% |
| Jan. 9, 2026 | Lippis Daniel J. | CVP, TAVR | M | Employee Stock Option (Right to Acquire) | 1019 | $0.00 | 4,076.0000 | 658,200,000 | 20.00% | 0.00% |
| Jan. 9, 2026 | Lippis Daniel J. | CVP, TAVR | M | Common Stock | 1019 | $59.26 | 23,020.9103 | 658,200,000 | 4.63% | 0.00% |
| Jan. 6, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 11340 | $59.26 | 217,179.9523 | 658,200,000 | 5.51% | 0.00% |
| Jan. 6, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 11340 | $0.00 | 34,020.0000 | 658,200,000 | 25.00% | 0.00% |
| Jan. 6, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 8708 | $85.98 | 205,839.9523 | 658,200,000 | 4.06% | 0.00% |
| Jan. 6, 2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 2632 | $84.62 | 214,547.9523 | 658,200,000 | 1.21% | 0.00% |
| Dec. 12, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | G | Common Stock | 7100 | $0.00 | 205,839.9523 | 658,200,000 | 3.33% | 0.00% |
| Dec. 12, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5486 | $83.79 | 218,839.9523 | 658,200,000 | 2.45% | 0.00% |
| Dec. 12, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 1019 | $0.00 | 5,095.0000 | 658,200,000 | 16.67% | 0.00% |
| Dec. 12, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5900 | $83.74 | 212,939.9523 | 658,200,000 | 2.70% | 0.00% |
| Dec. 12, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 1019 | $84.03 | 22,001.9103 | 658,200,000 | 4.43% | 0.00% |
| Dec. 12, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 1019 | $59.26 | 23,020.9103 | 658,200,000 | 4.63% | 0.00% |
| Dec. 12, 2025 | STONE HEISZ LESLIE | Director | S | Common Stock | 2615 | $83.41 | 30,948.0000 | 658,200,000 | 7.79% | 0.00% |
| Dec. 11, 2025 | Chopra Daveen | CVP, TMTT & Surgical | S | Common Stock | 2000 | $84.38 | 32,201.0000 | 658,200,000 | 5.85% | 0.00% |
| Dec. 9, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 3863 | $0.00 | 93,178.3998 | 658,200,000 | 3.98% | 0.00% |
| Dec. 10, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 11340 | $0.00 | 45,360.0000 | 658,200,000 | 20.00% | 0.00% |
| Dec. 10, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 11340 | $83.83 | 224,326.0698 | 658,200,000 | 4.81% | 0.00% |
| Dec. 10, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 11340 | $59.26 | 235,666.0698 | 658,200,000 | 5.06% | 0.00% |
| Dec. 8, 2025 | Zovighian Bernard J | CEO | M | Common Stock | 25350 | $59.26 | 118,528.3998 | 658,200,000 | 27.21% | 0.00% |
| Dec. 10, 2025 | Zovighian Bernard J | CEO | S | Common Stock | 3863 | $83.45 | 93,178.3998 | 658,200,000 | 3.98% | 0.00% |
| Dec. 9, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 3863 | $0.00 | 97,041.3998 | 658,200,000 | 4.15% | 0.00% |
| Dec. 8, 2025 | Zovighian Bernard J | CEO | S | Common Stock | 21487 | $85.21 | 97,041.3998 | 658,200,000 | 18.13% | 0.00% |
| Dec. 8, 2025 | Zovighian Bernard J | CEO | M | Employee Stock Option (Right to Acquire) | 25350 | $0.00 | 25,350.0000 | 658,200,000 | 50.00% | 0.00% |
| Dec. 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7700 | $59.26 | 313,916.0000 | 658,200,000 | 2.51% | 0.00% |
| Dec. 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7700 | $84.47 | 306,216.0000 | 658,200,000 | 2.45% | 0.00% |
| Dec. 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7700 | $0.00 | 39,000.0000 | 658,200,000 | 16.49% | 0.00% |
| Dec. 8, 2025 | Markowitz Wayne | CVP, JAPAC | S | Common Stock | 583 | $86.01 | 17,562.8708 | 658,200,000 | 3.21% | 0.00% |
| Nov. 13, 2025 | Dahl Andrew M. | SVP, Corporate Controller | A | Common Stock | 1160 | $0.00 | 9,183.0740 | 658,200,000 | 14.46% | 0.00% |
| Nov. 10, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 13000 | $59.26 | 319,216.0000 | 658,200,000 | 4.25% | 0.00% |
| Nov. 10, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 1020 | $0.00 | 6,114.0000 | 658,200,000 | 14.30% | 0.00% |
| Nov. 10, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 1020 | $82.55 | 22,001.9103 | 658,200,000 | 4.43% | 0.00% |
| Nov. 10, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 1020 | $59.26 | 23,021.9103 | 658,200,000 | 4.64% | 0.00% |
| Nov. 10, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 13000 | $0.00 | 46,700.0000 | 658,200,000 | 21.78% | 0.00% |
| Nov. 10, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 2974 | $83.30 | 316,242.0000 | 658,200,000 | 0.93% | 0.00% |
| Nov. 10, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 10026 | $83.02 | 306,216.0000 | 658,200,000 | 3.17% | 0.00% |
| Sept. 13, 2025 | Dahl Andrew M. | SVP, Corporate Controller | F | Common Stock | 262 | $77.57 | 7,926.9331 | 657,600,000 | 3.20% | 0.00% |
| Sept. 14, 2025 | Markowitz Wayne | CVP, JAPAC | F | Common Stock | 650 | $77.57 | 18,145.8708 | 657,600,000 | 3.46% | 0.00% |
| Sept. 11, 2025 | Markowitz Wayne | CVP, JAPAC | A | Common Stock | 6410 | $0.00 | 18,795.8708 | 657,600,000 | 51.75% | 0.00% |
| Sept. 11, 2025 | Chopra Daveen | CVP, TMTT & Surgical | A | Common Stock | 3205 | $0.00 | 34,201.0000 | 657,600,000 | 10.34% | 0.00% |
| Aug. 25, 2025 | Chopra Daveen | CVP, TMTT | S | Common Stock | 2500 | $81.95 | 30,996.0000 | 657,600,000 | 7.46% | 0.00% |
| Aug. 18, 2025 | Wood Larry L | Global President TAVR & Surg | M | Common Stock | 8950 | $59.26 | 215,998.5616 | 657,600,000 | 4.32% | 0.00% |
| Aug. 18, 2025 | Wood Larry L | Global President TAVR & Surg | S | Common Stock | 8950 | $78.06 | 207,048.5616 | 657,600,000 | 4.14% | 0.00% |
| Aug. 18, 2025 | Wood Larry L | Global President TAVR & Surg | M | Employee Stock Option (Right to Acquire) | 8950 | $0.00 | 35,800.0000 | 657,600,000 | 20.00% | 0.00% |
| July 28, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 4114 | $79.46 | 22,001.9103 | 657,600,000 | 15.75% | 0.00% |
| July 11, 2025 | Bruls Annette | CVP, EMEACLA | F | Common Stock | 109 | $78.80 | 14,171.0000 | 657,600,000 | 0.76% | 0.00% |
| July 7, 2025 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 333 | $76.79 | 26,115.9103 | 657,600,000 | 1.26% | 0.00% |
| June 16, 2025 | Wood Larry L | Global President TAVR & Surg | M | Common Stock | 8950 | $59.26 | 215,998.5616 | 655,900,000 | 4.32% | 0.00% |
| June 16, 2025 | Wood Larry L | Global President TAVR & Surg | M | Employee Stock Option (Right to Acquire) | 8950 | $0.00 | 44,750.0000 | 655,900,000 | 16.67% | 0.00% |
| June 16, 2025 | Wood Larry L | Global President TAVR & Surg | S | Common Stock | 8950 | $75.23 | 207,048.5616 | 655,900,000 | 4.14% | 0.00% |
| May 30, 2025 | Zovighian Bernard J | CEO | S | Common Stock | 16099 | $77.21 | 94,145.3998 | 655,900,000 | 14.60% | 0.00% |
| June 3, 2025 | Zovighian Bernard J | CEO | S | Common Stock | 967 | $77.32 | 93,178.3998 | 655,900,000 | 1.03% | 0.00% |
| June 2, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 2570 | $77.40 | 224,326.0698 | 655,900,000 | 1.13% | 0.00% |
| May 22, 2025 | Chopra Daveen | CVP, TMTT | S | Common Stock | 1500 | $75.08 | 33,496.0000 | 655,900,000 | 4.29% | 0.00% |
| May 16, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 5816 | $0.00 | 110,244.3998 | 655,900,000 | 5.01% | 0.00% |
| May 16, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 5816 | $0.00 | 110,244.3998 | 655,900,000 | 5.57% | 0.00% |
| May 13, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 2771 | $0.00 | 110,244.3998 | 655,900,000 | 2.58% | 0.00% |
| May 13, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 2771 | $0.00 | 110,244.3998 | 655,900,000 | 2.45% | 0.00% |
| May 11, 2025 | Zovighian Bernard J | CEO | F | Common Stock | 2860 | $73.68 | 113,015.3998 | 655,900,000 | 2.47% | 0.00% |
| May 11, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 1200 | $73.68 | 306,216.0000 | 655,900,000 | 0.39% | 0.00% |
| May 11, 2025 | Chopra Daveen | CVP, TMTT | F | Common Stock | 580 | $73.68 | 34,996.0000 | 655,900,000 | 1.63% | 0.00% |
| May 11, 2025 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 271 | $73.68 | 26,345.1066 | 655,900,000 | 1.02% | 0.00% |
| May 11, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 816 | $73.68 | 226,896.0698 | 655,900,000 | 0.36% | 0.00% |
| May 11, 2025 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 988 | $73.68 | 207,048.5616 | 655,900,000 | 0.47% | 0.00% |
| May 8, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | A | Employee Stock Option (Right to Acquire) | 75200 | $0.00 | 75,200.0000 | 655,900,000 | 9999.99% | 0.01% |
| May 9, 2025 | VALERIANI NICHOLAS J | Director | A | Common Stock | 5564 | $0.00 | 79,296.0000 | 655,900,000 | 7.55% | 0.00% |
| May 9, 2025 | Sequeira Ramona | Director | A | Common Stock | 3528 | $0.00 | 17,604.0000 | 655,900,000 | 25.06% | 0.00% |
| May 9, 2025 | LORANGER STEVEN R | Director | A | Common Stock | 3528 | $0.00 | 78,900.0000 | 655,900,000 | 4.68% | 0.00% |
| May 9, 2025 | LORANGER STEVEN R | Director | A | Common Stock | 1154 | $0.00 | 80,054.0000 | 655,900,000 | 1.46% | 0.00% |
| May 9, 2025 | LAVIOLETTE PAUL A | Director | A | Common Stock | 3528 | $0.00 | 14,301.0000 | 655,900,000 | 32.75% | 0.00% |
| May 9, 2025 | STONE HEISZ LESLIE | Director | A | Common Stock | 3528 | $0.00 | 33,563.0000 | 655,900,000 | 11.75% | 0.00% |
| May 9, 2025 | GALLAHUE KIERAN | Director | A | Common Stock | 3528 | $0.00 | 78,502.0000 | 655,900,000 | 4.71% | 0.00% |
| May 9, 2025 | GALLAHUE KIERAN | Director | A | Common Stock | 1154 | $0.00 | 79,656.0000 | 655,900,000 | 1.47% | 0.00% |
| May 9, 2025 | Feinberg David T | Director | A | Common Stock | 3528 | $0.00 | 5,836.0000 | 655,900,000 | 152.86% | 0.00% |
| May 9, 2025 | Davis Leslie C. | Director | A | Common Stock | 3528 | $0.00 | 6,583.0000 | 655,900,000 | 115.48% | 0.00% |
| May 8, 2025 | Bruls Annette | CVP, EMEACLA | A | Common Stock | 6200 | $0.00 | 14,280.0000 | 655,900,000 | 76.73% | 0.00% |
| May 8, 2025 | Bruls Annette | CVP, EMEACLA | A | Employee Stock Option (Right to Acquire) | 31600 | $0.00 | 31,600.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 8, 2025 | Bruls Annette | CVP, EMEACLA | A | Performance Rights | 6200 | $0.00 | 6,200.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 8, 2025 | Lippis Daniel J. | CVP, JAPAC | A | Common Stock | 4225 | $0.00 | 26,616.1066 | 655,900,000 | 18.87% | 0.00% |
| May 9, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 330 | $45.28 | 26,946.1066 | 655,900,000 | 1.24% | 0.00% |
| May 9, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 330 | $74.42 | 26,616.1066 | 655,900,000 | 1.22% | 0.00% |
| May 8, 2025 | Lippis Daniel J. | CVP, JAPAC | A | Employee Stock Option (Right to Acquire) | 21500 | $0.00 | 21,500.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 8, 2025 | Lippis Daniel J. | CVP, JAPAC | A | Performance Rights | 4225 | $0.00 | 4,225.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 9, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 330 | $0.00 | 0.0000 | 655,900,000 | 100.00% | 0.00% |
| May 8, 2025 | Dahl Andrew M. | SVP, Corporate Controller | A | Common Stock | 3335 | $0.00 | 8,106.5266 | 655,900,000 | 69.89% | 0.00% |
| May 8, 2025 | Dahl Andrew M. | SVP, Corporate Controller | A | Employee Stock Option (Right to Acquire) | 5670 | $0.00 | 5,670.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 7, 2025 | Markowitz Wayne | GM & SVP, Surgical | S | Common Stock | 268 | $75.08 | 9,299.1916 | 655,900,000 | 2.80% | 0.00% |
| May 7, 2025 | Markowitz Wayne | GM & SVP, Surgical | F | Common Stock | 300 | $74.92 | 8,999.1916 | 655,900,000 | 3.23% | 0.00% |
| May 8, 2025 | Markowitz Wayne | GM & SVP, Surgical | A | Common Stock | 3350 | $0.00 | 12,349.1916 | 655,900,000 | 37.23% | 0.00% |
| May 8, 2025 | Markowitz Wayne | GM & SVP, Surgical | A | Employee Stock Option (Right to Acquire) | 17100 | $0.00 | 17,100.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 8, 2025 | Markowitz Wayne | GM & SVP, Surgical | A | Performance Rights | 3350 | $0.00 | 3,350.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 7, 2025 | Chopra Daveen | CVP, TMTT | F | Common Stock | 627 | $74.92 | 26,376.0000 | 655,900,000 | 2.32% | 0.00% |
| May 8, 2025 | Chopra Daveen | CVP, TMTT | A | Common Stock | 9200 | $0.00 | 35,576.0000 | 655,900,000 | 34.88% | 0.00% |
| May 8, 2025 | Chopra Daveen | CVP, TMTT | A | Employee Stock Option (Right to Acquire) | 47000 | $0.00 | 47,000.0000 | 655,900,000 | 9999.99% | 0.01% |
| May 8, 2025 | Chopra Daveen | CVP, TMTT | A | Performance Rights | 9200 | $0.00 | 9,200.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 7, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 1406 | $74.92 | 294,016.0000 | 655,900,000 | 0.48% | 0.00% |
| May 8, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | A | Common Stock | 13400 | $0.00 | 307,416.0000 | 655,900,000 | 4.56% | 0.00% |
| May 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 318,666.0000 | 655,900,000 | 3.66% | 0.00% |
| May 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $74.40 | 307,416.0000 | 655,900,000 | 3.53% | 0.00% |
| May 8, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | A | Performance Rights | 13400 | $0.00 | 13,400.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 0.0000 | 655,900,000 | 100.00% | 0.00% |
| May 7, 2025 | Zovighian Bernard J | CEO | F | Common Stock | 4253 | $74.92 | 73,676.3998 | 655,900,000 | 5.46% | 0.00% |
| May 8, 2025 | Zovighian Bernard J | CEO | A | Common Stock | 43550 | $0.00 | 117,226.3998 | 655,900,000 | 59.11% | 0.01% |
| May 8, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 4122 | $0.00 | 113,104.3998 | 655,900,000 | 3.52% | 0.00% |
| May 8, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 4122 | $0.00 | 113,104.3998 | 655,900,000 | 3.78% | 0.00% |
| May 8, 2025 | Zovighian Bernard J | CEO | A | Employee Stock Option (Right to Acquire) | 244400 | $0.00 | 244,400.0000 | 655,900,000 | 9999.99% | 0.04% |
| May 8, 2025 | Zovighian Bernard J | CEO | A | Performance Rights | 43550 | $0.00 | 43,550.0000 | 655,900,000 | 9999.99% | 0.01% |
| May 7, 2025 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 819 | $74.92 | 196,986.5616 | 655,900,000 | 0.41% | 0.00% |
| May 8, 2025 | Wood Larry L | Global President TAVR & Surg | A | Common Stock | 11050 | $0.00 | 208,036.5616 | 655,900,000 | 5.61% | 0.00% |
| May 8, 2025 | Wood Larry L | Global President TAVR & Surg | A | Employee Stock Option (Right to Acquire) | 62000 | $0.00 | 62,000.0000 | 655,900,000 | 9999.99% | 0.01% |
| May 8, 2025 | Wood Larry L | Global President TAVR & Surg | A | Performance Rights | 11050 | $0.00 | 11,050.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 7, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 851 | $74.92 | 219,337.0698 | 655,900,000 | 0.39% | 0.00% |
| May 8, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | A | Common Stock | 8375 | $0.00 | 227,712.0698 | 655,900,000 | 3.82% | 0.00% |
| May 8, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | A | Employee Stock Option (Right to Acquire) | 47000 | $0.00 | 47,000.0000 | 655,900,000 | 9999.99% | 0.01% |
| May 8, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | A | Performance Rights | 8375 | $0.00 | 8,375.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 6, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 1036 | $0.00 | 73,807.3998 | 655,900,000 | 1.38% | 0.00% |
| May 5, 2025 | Zovighian Bernard J | CEO | S | Common Stock | 5980 | $74.91 | 74,843.3998 | 655,900,000 | 7.40% | 0.00% |
| May 5, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 1482 | $0.00 | 72,771.3998 | 655,900,000 | 2.08% | 0.00% |
| May 5, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 1482 | $0.00 | 80,823.3998 | 655,900,000 | 1.80% | 0.00% |
| May 5, 2025 | Zovighian Bernard J | CEO | M | Common Stock | 7462 | $45.28 | 82,305.3998 | 655,900,000 | 9.97% | 0.00% |
| May 4, 2025 | Zovighian Bernard J | CEO | F | Common Stock | 543 | $75.65 | 74,843.3998 | 655,900,000 | 0.72% | 0.00% |
| May 3, 2025 | Zovighian Bernard J | CEO | F | Common Stock | 527 | $75.65 | 75,386.3998 | 655,900,000 | 0.69% | 0.00% |
| May 5, 2025 | Zovighian Bernard J | CEO | M | Employee Stock Option (Right to Acquire) | 7462 | $0.00 | 0.0000 | 655,900,000 | 100.00% | 0.00% |
| May 6, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 1036 | $0.00 | 73,807.3998 | 655,900,000 | 1.42% | 0.00% |
| May 4, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 648 | $75.65 | 295,422.0000 | 655,900,000 | 0.22% | 0.00% |
| May 4, 2025 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 410 | $75.65 | 197,805.5616 | 655,900,000 | 0.21% | 0.00% |
| May 3, 2025 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 225 | $75.65 | 22,638.1066 | 655,900,000 | 0.98% | 0.00% |
| May 4, 2025 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 247 | $75.65 | 22,391.1066 | 655,900,000 | 1.09% | 0.00% |
| May 3, 2025 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 396 | $75.65 | 198,215.5616 | 655,900,000 | 0.20% | 0.00% |
| May 3, 2025 | Chopra Daveen | CVP, TMTT | F | Common Stock | 291 | $75.65 | 27,292.0000 | 655,900,000 | 1.05% | 0.00% |
| May 4, 2025 | Chopra Daveen | CVP, TMTT | F | Common Stock | 289 | $75.65 | 27,003.0000 | 655,900,000 | 1.06% | 0.00% |
| May 3, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 480 | $75.65 | 220,696.0698 | 655,900,000 | 0.22% | 0.00% |
| May 4, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 508 | $75.65 | 220,188.0698 | 655,900,000 | 0.23% | 0.00% |
| May 3, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 635 | $75.65 | 296,070.0000 | 655,900,000 | 0.21% | 0.00% |
| April 14, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 9500 | $45.28 | 230,676.0698 | 655,900,000 | 4.30% | 0.00% |
| April 14, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 9500 | $69.81 | 221,176.0698 | 655,900,000 | 4.12% | 0.00% |
| April 14, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 9500 | $0.00 | 0.0000 | 655,900,000 | 100.00% | 0.00% |
| April 8, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 300 | $0.00 | 330.0000 | 655,900,000 | 47.62% | 0.00% |
| April 8, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 300 | $45.28 | 23,163.1066 | 655,900,000 | 1.31% | 0.00% |
| April 8, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 300 | $70.61 | 22,863.1066 | 655,900,000 | 1.30% | 0.00% |
| March 26, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 307,955.0000 | 654,800,000 | 3.79% | 0.00% |
| March 26, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 11,250.0000 | 654,800,000 | 50.00% | 0.00% |
| March 26, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $70.87 | 296,705.0000 | 654,800,000 | 3.65% | 0.00% |
| March 13, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 9500 | $45.28 | 230,353.0991 | 654,800,000 | 4.30% | 0.00% |
| March 13, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 9500 | $67.96 | 220,853.0991 | 654,800,000 | 4.12% | 0.00% |
| March 13, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 9500 | $0.00 | 9,500.0000 | 654,800,000 | 50.00% | 0.00% |
| March 10, 2025 | Zovighian Bernard J | CEO | M | Common Stock | 7463 | $45.28 | 80,477.1767 | 654,800,000 | 10.22% | 0.00% |
| March 10, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 1299 | $0.00 | 79,178.1767 | 654,800,000 | 1.61% | 0.00% |
| March 10, 2025 | Zovighian Bernard J | CEO | S | Common Stock | 6164 | $69.51 | 73,014.1767 | 654,800,000 | 7.78% | 0.00% |
| March 10, 2025 | Zovighian Bernard J | CEO | G | Common Stock | 1299 | $0.00 | 73,014.1767 | 654,800,000 | 1.81% | 0.00% |
| March 10, 2025 | Zovighian Bernard J | CEO | M | Employee Stock Option (Right to Acquire) | 7463 | $0.00 | 7,462.0000 | 654,800,000 | 50.00% | 0.00% |
| March 10, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 400 | $45.28 | 22,988.0651 | 654,800,000 | 1.77% | 0.00% |
| March 10, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 400 | $69.48 | 22,588.0651 | 654,800,000 | 1.74% | 0.00% |
| March 10, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 400 | $0.00 | 630.0000 | 654,800,000 | 38.83% | 0.00% |
| Feb. 28, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 307,955.0000 | 654,800,000 | 3.79% | 0.00% |
| Feb. 28, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 3490 | $71.38 | 304,465.0000 | 654,800,000 | 1.13% | 0.00% |
| Feb. 28, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7760 | $70.52 | 296,705.0000 | 654,800,000 | 2.55% | 0.00% |
| Feb. 28, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 22,500.0000 | 654,800,000 | 33.33% | 0.00% |
| Feb. 22, 2025 | Dahl Andrew M. | SVP, Corporate Controller | F | Common Stock | 176 | $73.30 | 4,684.1255 | 654,800,000 | 3.62% | 0.00% |
| Feb. 16, 2025 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 214 | $76.19 | 22,975.0651 | 654,800,000 | 0.92% | 0.00% |
| Feb. 17, 2025 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 165 | $76.19 | 22,810.0651 | 654,800,000 | 0.72% | 0.00% |
| Feb. 18, 2025 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 222 | $76.19 | 22,588.0651 | 654,800,000 | 0.97% | 0.00% |
| Feb. 16, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 174 | $76.19 | 296,705.0000 | 654,800,000 | 0.06% | 0.00% |
| Feb. 16, 2025 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 333 | $76.19 | 198,340.9093 | 654,800,000 | 0.17% | 0.00% |
| Feb. 14, 2025 | LORANGER STEVEN R | Director | M | Director Stock Option (Right to Acquire) | 5739 | $0.00 | 0.0000 | 654,800,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | LORANGER STEVEN R | Director | M | Common Stock | 5739 | $45.32 | 81,111.0000 | 654,800,000 | 7.61% | 0.00% |
| Feb. 14, 2025 | LORANGER STEVEN R | Director | S | Common Stock | 5739 | $76.42 | 75,372.0000 | 654,800,000 | 7.08% | 0.00% |
| Feb. 13, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 308,129.0000 | 654,800,000 | 3.79% | 0.00% |
| Feb. 13, 2025 | STONE HEISZ LESLIE | Director | S | Common Stock | 5739 | $75.86 | 30,035.0000 | 654,800,000 | 16.04% | 0.00% |
| Feb. 13, 2025 | STONE HEISZ LESLIE | Director | M | Director Stock Option (Right to Acquire) | 5739 | $0.00 | 0.0000 | 654,800,000 | 100.00% | 0.00% |
| Feb. 13, 2025 | STONE HEISZ LESLIE | Director | M | Common Stock | 5739 | $45.32 | 35,774.0000 | 654,800,000 | 19.11% | 0.00% |
| Feb. 13, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 500 | $0.00 | 1,030.0000 | 654,800,000 | 32.68% | 0.00% |
| Feb. 13, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 500 | $76.34 | 23,189.0651 | 654,800,000 | 2.11% | 0.00% |
| Feb. 13, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 500 | $45.28 | 23,689.0651 | 654,800,000 | 2.16% | 0.00% |
| Feb. 13, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 6500 | $0.00 | 19,000.0000 | 654,800,000 | 25.49% | 0.00% |
| Feb. 13, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 6400 | $75.74 | 220,813.9654 | 654,800,000 | 2.82% | 0.00% |
| Feb. 13, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 100 | $76.26 | 227,213.9654 | 654,800,000 | 0.04% | 0.00% |
| Feb. 13, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 6500 | $45.28 | 227,313.9654 | 654,800,000 | 2.94% | 0.00% |
| Feb. 13, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 33,750.0000 | 654,800,000 | 25.00% | 0.00% |
| Feb. 13, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $75.76 | 296,879.0000 | 654,800,000 | 3.65% | 0.00% |
| Jan. 16, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,704.3329 | 654,800,000 | 2.27% | 0.00% |
| Jan. 16, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 25,500.0000 | 654,800,000 | 16.39% | 0.00% |
| Jan. 16, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 500 | $45.28 | 23,689.0651 | 654,800,000 | 2.16% | 0.00% |
| Jan. 16, 2025 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 500 | $68.76 | 23,189.0651 | 654,800,000 | 2.11% | 0.00% |
| Jan. 16, 2025 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 500 | $0.00 | 1,530.0000 | 654,800,000 | 24.63% | 0.00% |
| Jan. 16, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $68.75 | 220,704.3329 | 654,800,000 | 2.22% | 0.00% |
| Dec. 16, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 2500 | $45.28 | 25,689.0651 | 654,300,000 | 10.78% | 0.00% |
| Dec. 16, 2024 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 2500 | $74.08 | 23,189.0651 | 654,300,000 | 9.73% | 0.00% |
| Dec. 16, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 2500 | $0.00 | 2,030.0000 | 654,300,000 | 55.19% | 0.00% |
| Dec. 9, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 11250 | $45.28 | 308,129.0000 | 654,300,000 | 3.79% | 0.00% |
| Dec. 9, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 11250 | $71.68 | 296,879.0000 | 654,300,000 | 3.65% | 0.00% |
| Dec. 9, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 11250 | $0.00 | 45,000.0000 | 654,300,000 | 20.00% | 0.00% |
| Dec. 9, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $71.75 | 220,704.3329 | 654,300,000 | 2.22% | 0.00% |
| Dec. 9, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,704.3329 | 654,300,000 | 2.27% | 0.00% |
| Dec. 9, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 30,500.0000 | 654,300,000 | 14.08% | 0.00% |
| Dec. 6, 2024 | Chopra Daveen | CVP, TMTT | S | Common Stock | 1750 | $73.27 | 27,583.0000 | 654,300,000 | 5.97% | 0.00% |
| Dec. 6, 2024 | Markowitz Wayne | GM & SVP, Surgical | S | Common Stock | 583 | $73.27 | 9,493.8468 | 654,300,000 | 5.79% | 0.00% |
| Nov. 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,704.3329 | 654,300,000 | 2.27% | 0.00% |
| Nov. 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $65.57 | 220,704.3329 | 654,300,000 | 2.22% | 0.00% |
| Nov. 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 35,500.0000 | 654,300,000 | 12.35% | 0.00% |
| Nov. 5, 2024 | Wood Larry L | Global President TAVR & Surg | S | Common Stock | 25000 | $65.91 | 198,673.9093 | 654,300,000 | 11.18% | 0.00% |
| Oct. 15, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,704.3329 | 654,300,000 | 2.27% | 0.00% |
| Oct. 15, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $69.51 | 220,704.3329 | 654,300,000 | 2.22% | 0.00% |
| Oct. 15, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 40,500.0000 | 654,300,000 | 10.99% | 0.00% |
| Sept. 14, 2024 | Markowitz Wayne | GM & SVP, Surgical | F | Common Stock | 648 | $68.52 | 10,033.0463 | 653,500,000 | 6.07% | 0.00% |
| Sept. 13, 2024 | Dahl Andrew M. | SVP, Corporate Controller | A | Common Stock | 2920 | $0.00 | 4,690.7834 | 653,500,000 | 164.90% | 0.00% |
| Sept. 11, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,704.3329 | 653,500,000 | 2.27% | 0.00% |
| Sept. 11, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $66.77 | 220,704.3329 | 653,500,000 | 2.22% | 0.00% |
| Sept. 11, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 45,500.0000 | 653,500,000 | 9.90% | 0.00% |
| Sept. 3, 2024 | Szyman Catherine M. | CVP, Critical Care | A | Common Stock | 10910 | $0.00 | 86,817.4373 | 653,500,000 | 14.37% | 0.00% |
| Sept. 3, 2024 | Szyman Catherine M. | CVP, Critical Care | F | Common Stock | 5530 | $69.96 | 81,287.4373 | 653,500,000 | 6.37% | 0.00% |
| Aug. 20, 2024 | Chopra Daveen | CVP, TMTT | S | Common Stock | 1250 | $69.95 | 29,333.0000 | 653,500,000 | 4.09% | 0.00% |
| Aug. 14, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,704.3329 | 653,500,000 | 2.27% | 0.00% |
| Aug. 14, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $66.08 | 220,704.3329 | 653,500,000 | 2.22% | 0.00% |
| Aug. 14, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 50,500.0000 | 653,500,000 | 9.01% | 0.00% |
| July 11, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 500 | $45.28 | 23,689.0651 | 653,500,000 | 2.16% | 0.00% |
| July 11, 2024 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 500 | $94.18 | 23,189.0651 | 653,500,000 | 2.11% | 0.00% |
| July 11, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 500 | $0.00 | 4,530.0000 | 653,500,000 | 9.94% | 0.00% |
| July 10, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,702.7547 | 653,500,000 | 2.27% | 0.00% |
| July 10, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $93.29 | 220,702.7547 | 653,500,000 | 2.22% | 0.00% |
| July 10, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 55,500.0000 | 653,500,000 | 8.26% | 0.00% |
| July 10, 2024 | Feinberg David T | Director | A | Common Stock | 2308 | $0.00 | 2,308.0000 | 653,500,000 | 9999.99% | 0.00% |
| July 7, 2024 | Szyman Catherine M. | CVP, Critical Care | F | Common Stock | 258 | $92.32 | 75,907.4373 | 653,500,000 | 0.34% | 0.00% |
| July 7, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 410 | $92.32 | 23,189.0651 | 653,500,000 | 1.74% | 0.00% |
| July 7, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | F | Common Stock | 82 | $92.32 | 184,685.8054 | 653,500,000 | 0.04% | 0.00% |
| June 20, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 535 | $0.00 | 5,030.0000 | 651,800,000 | 9.61% | 0.00% |
| June 20, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 5625 | $0.00 | 56,250.0000 | 651,800,000 | 9.09% | 0.00% |
| June 20, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 5225 | $87.47 | 296,879.0000 | 651,800,000 | 1.73% | 0.00% |
| June 20, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 400 | $88.11 | 302,104.0000 | 651,800,000 | 0.13% | 0.00% |
| June 20, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 5625 | $45.28 | 302,504.0000 | 651,800,000 | 1.89% | 0.00% |
| June 20, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 535 | $45.28 | 24,047.7443 | 651,800,000 | 2.28% | 0.00% |
| June 20, 2024 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 535 | $90.00 | 23,512.7443 | 651,800,000 | 2.22% | 0.00% |
| June 12, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $87.54 | 220,702.7547 | 651,800,000 | 2.22% | 0.00% |
| June 12, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 225,702.7547 | 651,800,000 | 2.27% | 0.00% |
| June 12, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 60,500.0000 | 651,800,000 | 7.63% | 0.00% |
| May 30, 2024 | Zovighian Bernard J | CEO | S | Common Stock | 8617 | $87.68 | 71,485.5557 | 651,800,000 | 10.76% | 0.00% |
| May 21, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 5625 | $45.28 | 302,504.0000 | 651,800,000 | 1.89% | 0.00% |
| May 21, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 5625 | $0.00 | 61,875.0000 | 651,800,000 | 8.33% | 0.00% |
| May 21, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 5625 | $90.45 | 296,879.0000 | 651,800,000 | 1.86% | 0.00% |
| May 10, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5000 | $45.28 | 226,516.7547 | 651,800,000 | 2.26% | 0.00% |
| May 11, 2024 | Zovighian Bernard J | CEO | F | Common Stock | 2854 | $86.72 | 80,102.5557 | 651,800,000 | 3.44% | 0.00% |
| May 10, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 5000 | $0.00 | 65,500.0000 | 651,800,000 | 7.09% | 0.00% |
| May 11, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 814 | $86.72 | 220,702.7547 | 651,800,000 | 0.37% | 0.00% |
| May 10, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 5000 | $87.81 | 221,516.7547 | 651,800,000 | 2.21% | 0.00% |
| May 11, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | F | Common Stock | 229 | $86.72 | 37,490.1980 | 651,800,000 | 0.61% | 0.00% |
| May 11, 2024 | Szyman Catherine M. | CVP, Critical Care | F | Common Stock | 827 | $86.72 | 76,165.4373 | 651,800,000 | 1.07% | 0.00% |
| May 11, 2024 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 985 | $86.72 | 224,021.6171 | 651,800,000 | 0.44% | 0.00% |
| May 11, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 377 | $86.72 | 23,512.7443 | 651,800,000 | 1.58% | 0.00% |
| May 11, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | F | Common Stock | 21 | $86.72 | 184,767.8055 | 651,800,000 | 0.01% | 0.00% |
| May 11, 2024 | Chopra Daveen | CVP, TMTT | F | Common Stock | 821 | $86.72 | 30,583.0000 | 651,800,000 | 2.61% | 0.00% |
| May 11, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 1198 | $86.72 | 296,879.0000 | 651,800,000 | 0.40% | 0.00% |
| May 7, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | A | Performance Rights | 11075 | $0.00 | 11,075.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | A | Common Stock | 2445 | $0.00 | 37,897.1980 | 651,800,000 | 6.90% | 0.00% |
| May 7, 2024 | Szyman Catherine M. | CVP, Critical Care | A | Common Stock | 32025 | $0.00 | 77,601.4373 | 651,800,000 | 70.27% | 0.00% |
| May 7, 2024 | Szyman Catherine M. | CVP, Critical Care | F | Common Stock | 609 | $85.09 | 76,992.4373 | 651,800,000 | 0.78% | 0.00% |
| May 7, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | A | Employee Stock Option (Right to Acquire) | 4820 | $0.00 | 4,820.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Markowitz Wayne | GM & SVP, Surgical | A | Common Stock | 3350 | $0.00 | 10,648.5547 | 651,800,000 | 45.90% | 0.00% |
| May 7, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | F | Common Stock | 178 | $85.09 | 37,719.1980 | 651,800,000 | 0.47% | 0.00% |
| May 7, 2024 | Markowitz Wayne | GM & SVP, Surgical | A | Employee Stock Option (Right to Acquire) | 17800 | $0.00 | 17,800.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Markowitz Wayne | GM & SVP, Surgical | A | Performance Rights | 3350 | $0.00 | 3,350.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | A | Common Stock | 4660 | $0.00 | 21,575.7443 | 651,800,000 | 27.55% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 857 | $36.75 | 25,332.7443 | 651,800,000 | 3.50% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 586 | $85.09 | 24,746.7443 | 651,800,000 | 2.31% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 857 | $85.60 | 23,889.7443 | 651,800,000 | 3.46% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | A | Employee Stock Option (Right to Acquire) | 15500 | $0.00 | 15,500.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 857 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | A | Performance Rights | 2900 | $0.00 | 2,900.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Chopra Daveen | CVP, TMTT | A | Common Stock | 7000 | $0.00 | 31,851.0000 | 651,800,000 | 28.17% | 0.00% |
| May 7, 2024 | Chopra Daveen | CVP, TMTT | F | Common Stock | 447 | $85.09 | 31,404.0000 | 651,800,000 | 1.40% | 0.00% |
| May 7, 2024 | Chopra Daveen | CVP, TMTT | A | Employee Stock Option (Right to Acquire) | 37200 | $0.00 | 37,200.0000 | 651,800,000 | 9999.99% | 0.01% |
| May 7, 2024 | Chopra Daveen | CVP, TMTT | A | Performance Rights | 7000 | $0.00 | 7,000.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | A | Common Stock | 7125 | $0.00 | 184,834.8055 | 651,800,000 | 4.01% | 0.00% |
| May 7, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | F | Common Stock | 46 | $85.09 | 184,788.8055 | 651,800,000 | 0.02% | 0.00% |
| May 7, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | A | Employee Stock Option (Right to Acquire) | 42200 | $0.00 | 42,200.0000 | 651,800,000 | 9999.99% | 0.01% |
| May 7, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | A | Performance Rights | 7125 | $0.00 | 7,125.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Wood Larry L | Global President TAVR & Surg | A | Common Stock | 8725 | $0.00 | 225,701.6171 | 651,800,000 | 4.02% | 0.00% |
| May 7, 2024 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 695 | $85.09 | 225,006.6171 | 651,800,000 | 0.31% | 0.00% |
| May 7, 2024 | Wood Larry L | Global President TAVR & Surg | A | Employee Stock Option (Right to Acquire) | 51700 | $0.00 | 51,700.0000 | 651,800,000 | 9999.99% | 0.01% |
| May 7, 2024 | Wood Larry L | Global President TAVR & Surg | A | Performance Rights | 8725 | $0.00 | 8,725.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Zovighian Bernard J | CEO | A | Common Stock | 33500 | $0.00 | 83,603.5557 | 651,800,000 | 66.86% | 0.01% |
| May 7, 2024 | Zovighian Bernard J | CEO | F | Common Stock | 647 | $85.09 | 82,956.5557 | 651,800,000 | 0.77% | 0.00% |
| May 7, 2024 | Zovighian Bernard J | CEO | A | Employee Stock Option (Right to Acquire) | 178400 | $0.00 | 178,400.0000 | 651,800,000 | 9999.99% | 0.03% |
| May 7, 2024 | Zovighian Bernard J | CEO | A | Performance Rights | 33500 | $0.00 | 33,500.0000 | 651,800,000 | 9999.99% | 0.01% |
| May 7, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | A | Common Stock | 11075 | $0.00 | 298,867.0000 | 651,800,000 | 3.85% | 0.00% |
| May 7, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 790 | $85.09 | 298,077.0000 | 651,800,000 | 0.26% | 0.00% |
| May 7, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | A | Employee Stock Option (Right to Acquire) | 65500 | $0.00 | 65,500.0000 | 651,800,000 | 9999.99% | 0.01% |
| May 7, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | A | Common Stock | 6700 | $0.00 | 222,135.7547 | 651,800,000 | 3.11% | 0.00% |
| May 7, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 619 | $85.09 | 221,516.7547 | 651,800,000 | 0.28% | 0.00% |
| May 7, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | A | Employee Stock Option (Right to Acquire) | 39600 | $0.00 | 39,600.0000 | 651,800,000 | 9999.99% | 0.01% |
| May 7, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | A | Performance Rights | 6700 | $0.00 | 6,700.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | A | Common Stock | 2900 | $0.00 | 24,475.7443 | 651,800,000 | 13.44% | 0.00% |
| May 8, 2024 | LORANGER STEVEN R | Director | A | Common Stock | 3055 | $0.00 | 74,373.0000 | 651,800,000 | 4.28% | 0.00% |
| May 8, 2024 | LORANGER STEVEN R | Director | A | Common Stock | 999 | $0.00 | 75,372.0000 | 651,800,000 | 1.34% | 0.00% |
| May 8, 2024 | VALERIANI NICHOLAS J | Director | A | Common Stock | 4818 | $0.00 | 73,732.0000 | 651,800,000 | 6.99% | 0.00% |
| May 8, 2024 | Sequeira Ramona | Director | A | Common Stock | 3055 | $0.00 | 14,076.0000 | 651,800,000 | 27.72% | 0.00% |
| May 8, 2024 | LAVIOLETTE PAUL A | Director | A | Common Stock | 3055 | $0.00 | 10,773.0000 | 651,800,000 | 39.58% | 0.00% |
| May 8, 2024 | STONE HEISZ LESLIE | Director | A | Common Stock | 3055 | $0.00 | 30,035.0000 | 651,800,000 | 11.32% | 0.00% |
| May 8, 2024 | GALLAHUE KIERAN | Director | A | Common Stock | 3055 | $0.00 | 73,975.0000 | 651,800,000 | 4.31% | 0.00% |
| May 8, 2024 | GALLAHUE KIERAN | Director | A | Common Stock | 999 | $0.00 | 74,974.0000 | 651,800,000 | 1.35% | 0.00% |
| May 8, 2024 | Davis Leslie C. | Director | A | Common Stock | 3055 | $0.00 | 3,055.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 4, 2024 | Zovighian Bernard J | CEO | M | Performance Rights | 6265 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 6, 2024 | Zovighian Bernard J | CEO | P | Common Stock | 580 | $85.74 | 50,103.5557 | 651,800,000 | 1.17% | 0.00% |
| May 4, 2024 | Zovighian Bernard J | CEO | F | Common Stock | 3718 | $85.25 | 50,103.5557 | 651,800,000 | 6.91% | 0.00% |
| May 4, 2024 | Zovighian Bernard J | CEO | M | Common Stock | 6265 | $0.00 | 53,821.5557 | 651,800,000 | 13.17% | 0.00% |
| May 3, 2024 | Zovighian Bernard J | CEO | F | Common Stock | 527 | $85.06 | 47,556.5557 | 651,800,000 | 1.10% | 0.00% |
| May 4, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | M | Common Stock | 4157 | $0.00 | 177,968.8055 | 651,800,000 | 2.39% | 0.00% |
| May 3, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 634 | $85.06 | 284,758.0000 | 651,800,000 | 0.22% | 0.00% |
| May 4, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7465 | $0.00 | 292,223.0000 | 651,800,000 | 2.62% | 0.00% |
| May 4, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 4431 | $85.25 | 287,792.0000 | 651,800,000 | 1.52% | 0.00% |
| May 4, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Performance Rights | 7465 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 3, 2024 | Szyman Catherine M. | CVP, Critical Care | F | Common Stock | 479 | $85.06 | 43,222.4373 | 651,800,000 | 1.10% | 0.00% |
| May 4, 2024 | Szyman Catherine M. | CVP, Critical Care | M | Common Stock | 5796 | $0.00 | 49,018.4373 | 651,800,000 | 13.41% | 0.00% |
| May 4, 2024 | Szyman Catherine M. | CVP, Critical Care | F | Common Stock | 3442 | $85.25 | 45,576.4373 | 651,800,000 | 7.02% | 0.00% |
| May 4, 2024 | Szyman Catherine M. | CVP, Critical Care | M | Performance Rights | 5796 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 3, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | F | Common Stock | 106 | $85.06 | 35,572.1980 | 651,800,000 | 0.30% | 0.00% |
| May 4, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | F | Common Stock | 120 | $85.25 | 35,452.1980 | 651,800,000 | 0.34% | 0.00% |
| May 3, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 281 | $85.06 | 17,206.7443 | 651,800,000 | 1.61% | 0.00% |
| May 4, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 291 | $85.25 | 16,915.7443 | 651,800,000 | 1.69% | 0.00% |
| May 3, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | F | Common Stock | 37 | $85.06 | 173,811.8055 | 651,800,000 | 0.02% | 0.00% |
| May 6, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | F | Common Stock | 259 | $85.25 | 177,709.8055 | 651,800,000 | 0.15% | 0.00% |
| May 4, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | M | Performance Rights | 4157 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 3, 2024 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 395 | $85.06 | 213,842.6171 | 651,800,000 | 0.18% | 0.00% |
| May 4, 2024 | Wood Larry L | Global President TAVR & Surg | M | Common Stock | 6675 | $0.00 | 220,517.6171 | 651,800,000 | 3.12% | 0.00% |
| May 4, 2024 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 3541 | $85.25 | 216,976.6171 | 651,800,000 | 1.61% | 0.00% |
| May 4, 2024 | Wood Larry L | Global President TAVR & Surg | M | Performance Rights | 6675 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 3, 2024 | Chopra Daveen | CVP, TMTT | F | Common Stock | 291 | $85.06 | 22,459.0000 | 651,800,000 | 1.28% | 0.00% |
| May 4, 2024 | Chopra Daveen | CVP, TMTT | M | Common Stock | 4713 | $0.00 | 27,172.0000 | 651,800,000 | 20.98% | 0.00% |
| May 4, 2024 | Chopra Daveen | CVP, TMTT | F | Common Stock | 2321 | $85.25 | 24,851.0000 | 651,800,000 | 8.54% | 0.00% |
| May 4, 2024 | Chopra Daveen | CVP, TMTT | M | Performance Rights | 4713 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 3, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 479 | $85.06 | 213,055.7547 | 651,800,000 | 0.22% | 0.00% |
| May 4, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 5855 | $0.00 | 218,910.7547 | 651,800,000 | 2.75% | 0.00% |
| May 4, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | F | Common Stock | 3475 | $85.25 | 215,435.7547 | 651,800,000 | 1.59% | 0.00% |
| May 4, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Performance Rights | 5855 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 2, 2024 | MUSSALLEM MICHAEL A | Director | M | Employee Stock Option (Right to Acquire) | 29350 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 2, 2024 | MUSSALLEM MICHAEL A | Director | M | Common Stock | 29350 | $36.75 | 4,072,212.8200 | 651,800,000 | 0.73% | 0.00% |
| May 2, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 12207 | $85.02 | 4,060,005.8200 | 651,800,000 | 0.30% | 0.00% |
| May 2, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 17143 | $84.59 | 4,042,862.8200 | 651,800,000 | 0.42% | 0.00% |
| May 1, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | S | Common Stock | 12240 | $84.11 | 173,848.8055 | 651,800,000 | 6.58% | 0.00% |
| May 1, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | M | Common Stock | 14400 | $36.75 | 188,248.8055 | 651,800,000 | 8.28% | 0.00% |
| May 1, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | S | Common Stock | 2160 | $84.83 | 186,088.8055 | 651,800,000 | 1.15% | 0.00% |
| May 1, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | M | Employee Stock Option (Right to Acquire) | 14400 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| April 30, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 6550 | $85.74 | 285,392.0000 | 651,800,000 | 2.24% | 0.00% |
| April 30, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7250 | $36.75 | 292,642.0000 | 651,800,000 | 2.54% | 0.00% |
| April 30, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 700 | $86.40 | 291,942.0000 | 651,800,000 | 0.24% | 0.00% |
| April 30, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7250 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| April 9, 2024 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 857 | $92.34 | 17,487.7443 | 651,800,000 | 4.67% | 0.00% |
| April 9, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 857 | $36.75 | 18,344.7443 | 651,800,000 | 4.90% | 0.00% |
| April 9, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 857 | $0.00 | 857.0000 | 651,800,000 | 50.00% | 0.00% |
| April 8, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA | S | Common Stock | 14293 | $92.32 | 173,848.8055 | 651,800,000 | 7.60% | 0.00% |
| April 8, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA | M | Common Stock | 14400 | $36.75 | 188,248.8055 | 651,800,000 | 8.28% | 0.00% |
| April 8, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA | S | Common Stock | 107 | $92.65 | 188,141.8055 | 651,800,000 | 0.06% | 0.00% |
| April 8, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA | M | Employee Stock Option (Right to Acquire) | 14400 | $0.00 | 14,400.0000 | 651,800,000 | 50.00% | 0.00% |
| April 8, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 12500 | $36.75 | 225,964.6191 | 651,800,000 | 5.86% | 0.00% |
| April 8, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 100 | $92.66 | 225,864.6191 | 651,800,000 | 0.04% | 0.00% |
| April 8, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 12400 | $92.33 | 213,464.6191 | 651,800,000 | 5.49% | 0.00% |
| April 8, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 12500 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| April 4, 2024 | MUSSALLEM MICHAEL A | Director | M | Employee Stock Option (Right to Acquire) | 29350 | $0.00 | 29,350.0000 | 651,800,000 | 50.00% | 0.00% |
| April 4, 2024 | MUSSALLEM MICHAEL A | Director | M | Common Stock | 29350 | $36.75 | 4,072,212.8200 | 651,800,000 | 0.73% | 0.00% |
| April 4, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 200 | $94.19 | 4,072,012.8200 | 651,800,000 | 0.00% | 0.00% |
| April 4, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 2712 | $93.72 | 4,069,300.8200 | 651,800,000 | 0.07% | 0.00% |
| April 4, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 9820 | $91.54 | 4,059,480.8200 | 651,800,000 | 0.24% | 0.00% |
| April 4, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 16618 | $92.70 | 4,042,862.8200 | 651,800,000 | 0.41% | 0.00% |
| April 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 6387 | $94.81 | 285,392.0000 | 651,800,000 | 2.19% | 0.00% |
| April 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7255 | $36.75 | 292,647.0000 | 651,800,000 | 2.54% | 0.00% |
| April 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 868 | $95.51 | 291,779.0000 | 651,800,000 | 0.30% | 0.00% |
| April 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7255 | $0.00 | 7,250.0000 | 651,800,000 | 50.02% | 0.00% |
| March 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 14500 | $36.75 | 227,699.5938 | 650,500,000 | 6.80% | 0.00% |
| March 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 14500 | $91.01 | 213,199.5938 | 650,500,000 | 6.37% | 0.00% |
| March 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 14500 | $0.00 | 12,500.0000 | 650,500,000 | 53.70% | 0.00% |
| March 11, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | M | Employee Stock Option (Right to Acquire) | 14400 | $0.00 | 28,800.0000 | 650,500,000 | 33.33% | 0.00% |
| March 11, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | M | Common Stock | 14400 | $36.75 | 187,983.7785 | 650,500,000 | 8.30% | 0.00% |
| March 11, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | S | Common Stock | 14400 | $91.68 | 173,583.7785 | 650,500,000 | 7.66% | 0.00% |
| March 7, 2024 | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 1715 | $90.98 | 17,213.2105 | 650,500,000 | 9.06% | 0.00% |
| March 7, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 1715 | $36.75 | 18,928.2105 | 650,500,000 | 9.96% | 0.00% |
| March 7, 2024 | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 1715 | $0.00 | 1,714.0000 | 650,500,000 | 50.01% | 0.00% |
| March 4, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 13310 | $86.21 | 4,058,902.8200 | 650,500,000 | 0.33% | 0.00% |
| March 4, 2024 | MUSSALLEM MICHAEL A | Director | M | Employee Stock Option (Right to Acquire) | 29350 | $0.00 | 58,700.0000 | 650,500,000 | 33.33% | 0.00% |
| March 4, 2024 | MUSSALLEM MICHAEL A | Director | M | Common Stock | 29350 | $36.75 | 4,072,212.8200 | 650,500,000 | 0.73% | 0.00% |
| March 4, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 16040 | $87.05 | 4,042,862.8200 | 650,500,000 | 0.40% | 0.00% |
| Feb. 29, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7255 | $0.00 | 14,505.0000 | 650,500,000 | 33.34% | 0.00% |
| Feb. 29, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7255 | $85.59 | 285,392.0000 | 650,500,000 | 2.48% | 0.00% |
| Feb. 29, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7255 | $36.75 | 292,647.0000 | 650,500,000 | 2.54% | 0.00% |
| Feb. 23, 2024 | GALLAHUE KIERAN | Director | S | Common Stock | 3058 | $87.61 | 70,920.0000 | 650,500,000 | 4.13% | 0.00% |
| Feb. 23, 2024 | GALLAHUE KIERAN | Director | G | Common Stock | 7056 | $0.00 | 70,920.0000 | 650,500,000 | 9.05% | 0.00% |
| Feb. 23, 2024 | GALLAHUE KIERAN | Director | G | Common Stock | 7056 | $0.00 | 73,978.0000 | 650,500,000 | 10.54% | 0.00% |
| Feb. 23, 2024 | GALLAHUE KIERAN | Director | M | Director Stock Option (Right to Acquire) | 7056 | $0.00 | 0.0000 | 650,500,000 | 100.00% | 0.00% |
| Feb. 23, 2024 | GALLAHUE KIERAN | Director | M | Common Stock | 7056 | $36.86 | 77,976.0000 | 650,500,000 | 9.95% | 0.00% |
| Feb. 22, 2024 | Szyman Catherine M. | CVP, Critical Care | A | Common Stock | 8560 | $0.00 | 43,373.5710 | 650,500,000 | 24.59% | 0.00% |
| Feb. 22, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | A | Common Stock | 1998 | $0.00 | 35,494.1838 | 650,500,000 | 5.96% | 0.00% |
| Feb. 21, 2024 | Chopra Daveen | CVP, TMTT | S | Common Stock | 7000 | $86.75 | 22,750.0000 | 650,500,000 | 23.53% | 0.00% |
| Feb. 21, 2024 | Chopra Daveen | CVP, TMTT | M | Common Stock | 7000 | $59.26 | 30,950.0000 | 650,500,000 | 29.23% | 0.00% |
| Feb. 21, 2024 | Chopra Daveen | CVP, TMTT | S | Common Stock | 1200 | $86.67 | 29,750.0000 | 650,500,000 | 3.88% | 0.00% |
| Feb. 21, 2024 | Chopra Daveen | CVP, TMTT | M | Employee Stock Option (Right to Acquire) | 7000 | $0.00 | 0.0000 | 650,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 150 | $86.10 | 17,401.2105 | 650,500,000 | 0.85% | 0.00% |
| Feb. 16, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 207 | $86.04 | 17,551.2105 | 650,500,000 | 1.17% | 0.00% |
| Feb. 18, 2024 | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 188 | $86.10 | 17,213.2105 | 650,500,000 | 1.08% | 0.00% |
| Feb. 16, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | F | Common Stock | 174 | $86.04 | 285,392.0000 | 650,500,000 | 0.06% | 0.00% |
| Feb. 16, 2024 | Wood Larry L | Global President TAVR & Surg | F | Common Stock | 317 | $86.04 | 213,972.5918 | 650,500,000 | 0.15% | 0.00% |
| Feb. 15, 2024 | Szyman Catherine M. | CVP, Critical Care | M | Employee Stock Option (Right to Acquire) | 27000 | $0.00 | 0.0000 | 650,500,000 | 100.00% | 0.00% |
| Feb. 13, 2024 | Szyman Catherine M. | CVP, Critical Care | M | Employee Stock Option (Right to Acquire) | 20000 | $0.00 | 27,000.0000 | 650,500,000 | 42.55% | 0.00% |
| Feb. 13, 2024 | Szyman Catherine M. | CVP, Critical Care | M | Common Stock | 20000 | $36.75 | 54,813.5710 | 650,500,000 | 57.45% | 0.00% |
| Feb. 13, 2024 | Szyman Catherine M. | CVP, Critical Care | S | Common Stock | 20000 | $86.46 | 34,813.5710 | 650,500,000 | 36.49% | 0.00% |
| Feb. 15, 2024 | Szyman Catherine M. | CVP, Critical Care | M | Common Stock | 27000 | $36.75 | 61,813.5710 | 650,500,000 | 77.56% | 0.00% |
| Feb. 15, 2024 | Szyman Catherine M. | CVP, Critical Care | S | Common Stock | 27000 | $85.62 | 34,813.5710 | 650,500,000 | 43.68% | 0.00% |
| Feb. 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 11000 | $36.75 | 224,160.1775 | 650,500,000 | 5.16% | 0.00% |
| Feb. 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 470 | $86.35 | 223,690.1775 | 650,500,000 | 0.21% | 0.00% |
| Feb. 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 10530 | $85.81 | 213,160.1775 | 650,500,000 | 4.71% | 0.00% |
| Feb. 13, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 11000 | $0.00 | 27,000.0000 | 650,500,000 | 28.95% | 0.00% |
| Feb. 12, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | M | Common Stock | 12210 | $36.75 | 45,706.1838 | 650,500,000 | 36.45% | 0.00% |
| Feb. 12, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | M | Employee Stock Option (Right to Acquire) | 12210 | $0.00 | 0.0000 | 650,500,000 | 100.00% | 0.00% |
| Feb. 12, 2024 | SELLERS ROBERT W.A. | SVP, Corporate Controller | S | Common Stock | 12210 | $87.00 | 33,496.1838 | 650,500,000 | 26.71% | 0.00% |
| Feb. 8, 2024 | STONE HEISZ LESLIE | Director | M | Common Stock | 7056 | $36.86 | 34,036.0000 | 650,500,000 | 26.15% | 0.00% |
| Feb. 8, 2024 | STONE HEISZ LESLIE | Director | M | Director Stock Option (Right to Acquire) | 7056 | $0.00 | 0.0000 | 650,500,000 | 100.00% | 0.00% |
| Feb. 8, 2024 | STONE HEISZ LESLIE | Director | S | Common Stock | 7056 | $86.45 | 26,980.0000 | 650,500,000 | 20.73% | 0.00% |
| Feb. 5, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 9761 | $86.44 | 4,055,029.8200 | 650,500,000 | 0.24% | 0.00% |
| Feb. 5, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 6422 | $88.63 | 4,064,790.8200 | 650,500,000 | 0.16% | 0.00% |
| Feb. 5, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 1000 | $89.61 | 4,071,212.8200 | 650,500,000 | 0.02% | 0.00% |
| Feb. 5, 2024 | MUSSALLEM MICHAEL A | Director | M | Common Stock | 29350 | $36.75 | 4,072,212.8200 | 650,500,000 | 0.73% | 0.00% |
| Feb. 5, 2024 | MUSSALLEM MICHAEL A | Director | M | Employee Stock Option (Right to Acquire) | 29350 | $0.00 | 88,050.0000 | 650,500,000 | 25.00% | 0.00% |
| Feb. 5, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 12167 | $87.55 | 4,042,862.8200 | 650,500,000 | 0.30% | 0.00% |
| Feb. 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | Common Stock | 7255 | $78.29 | 285,566.0000 | 650,500,000 | 2.48% | 0.00% |
| Feb. 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Employee Stock Option (Right to Acquire) | 7255 | $0.00 | 21,760.0000 | 650,500,000 | 25.00% | 0.00% |
| Feb. 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | M | Common Stock | 7255 | $36.75 | 292,821.0000 | 650,500,000 | 2.54% | 0.00% |
| Jan. 12, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Common Stock | 10000 | $36.75 | 223,099.0631 | 650,500,000 | 4.69% | 0.00% |
| Jan. 12, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | Common Stock | 10000 | $75.67 | 213,099.0631 | 650,500,000 | 4.48% | 0.00% |
| Jan. 12, 2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | M | Employee Stock Option (Right to Acquire) | 10000 | $0.00 | 38,000.0000 | 650,500,000 | 20.83% | 0.00% |
| Jan. 5, 2024 | MUSSALLEM MICHAEL A | Director | M | Common Stock | 29350 | $36.75 | 4,072,212.8200 | 650,500,000 | 0.73% | 0.00% |
| Jan. 5, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 2500 | $73.46 | 4,069,712.8200 | 650,500,000 | 0.06% | 0.00% |
| Jan. 5, 2024 | MUSSALLEM MICHAEL A | Director | S | Common Stock | 26850 | $72.94 | 4,042,862.8200 | 650,500,000 | 0.66% | 0.00% |
| Jan. 5, 2024 | MUSSALLEM MICHAEL A | Director | M | Employee Stock Option (Right to Acquire) | 29350 | $0.00 | 117,400.0000 | 650,500,000 | 20.00% | 0.00% |